全体要約
軟骨再生医療市場は、2022年の売上を基に、2023年から2029年にかけての予測を地域別、セクター別に分析しています。市場は、アメリカ、中国、ヨーロッパなどの主要地域で成長が見込まれ、特にアメリカ市場は2022年から2029年にかけての成長率が注目されています。主要企業には、B. Braun Melsungen AG、Zimmer Biomet Holdings Inc.、Vericel Corporationなどが含まれ、2022年には上位2社が市場の大部分を占めています。
このレポートは、軟骨再生医療の製品タイプやアプリケーション、地域別の市場シェアを詳細に示しています。市場は、細胞ベースと非細胞ベースに分かれ、ヒアリン軟骨、弾性軟骨、線維軟骨の修復と再生に焦点を当てています。市場の成長機会やトレンドを把握するための包括的な分析が行われています。
関連する質問
B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix
製品セグメンテーションの重要なトレンド, 主要企業の市場参入戦略, 地理的フットプリントの分析
概要
このインサイトレポートは、グローバルな軟骨再生医療の状況を包括的に分析し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関する主要なトレンドを強調しています。また、このレポートは、軟骨再生医療のポートフォリオと能力、市場参入戦略、市場ポジション、地理的展開に焦点を当て、世界的に加速する軟骨再生医療市場におけるこれらの企業の独自の位置をよりよく理解するために、主要なグローバル企業の戦略を分析します。
このインサイトレポートは、軟骨用再生医療の世界的展望を形作る主要な市場動向、ドライバー、および影響要因を評価し、タイプ、用途、地理、及び市場規模別に予測を分解して、新たな機会のポケットを強調しています。何百ものボトムアップの定性および定量的な市場インプットに基づく透明な方法論を用いて、この研究予測は、現在の状態と将来の軌道に関する非常にニュアンスのある見方を提供します。
全球の軟骨再生医療市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長すると予測されています。2023年から2029年までの間にXX%の年平均成長率で成長すると予想されています。
米国の軟骨再生医療市場は、2022年のXX米ドルから2029年のXX米ドルへと増加すると推定されており、2023年から2029年の間にCAGR％となります。
中国の軟骨再生医療市場は、2022年のXX米ドルから2029年までにXX米ドルに増加する見込みで、2023年から2029年までの間にXX%の年平均成長率（CAGR）を記録する予想です。
ヨーロッパの再生医療市場は、2022年のXX米ドルから2029年にはXX米ドルに増加し、2023年から2029年までの間に年平均成長率（CAGR）がXX%と見込まれています。
グローバルな主要な軟骨再生医療企業は、B. Braun Melsungen AG、Zimmer Biomet Holdings Inc.、Vericel Corporation、Stryker Corporation、Smith & Nephew plc、Arthrex Inc.、CONMED Corporation、Collagen Solutions PLC、BioTissue Technologiesなどです。収益の観点から、2022年において、グローバルで最も大きな2社はほぼXX%のシェアを占めていました。
このレポートは、軟骨再生医療市場の製品タイプ、アプリケーション、主要プレーヤー、主要地域および国による包括的な概要、市場シェア、成長機会を提供します。
市場セグメンテーション
タイプによるセグメンテーション
細胞ベース
非細胞ベース
アプリケーションによるセグメンテーション
軟骨の修復と再生
弾性軟骨の修復と再生
線維軟骨の修復と再生。
このレポートでは、市場を地域別に分けています：
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から得た情報や、企業の範囲、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
B. ブラウン メルズンゲン AG
Zimmer Biomet ホールディングス社
ベリセル社
ストライカーコーポレーション
スミス・アンド・ネフュー plc
アースレックス社
コンメッド社
コラーゲンソリューションズPLC
バイオティッシュテクノロジーズ
セルジェニックス
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの軟骨再生医療市場規模、（2018年～2029年）
2.1.2 軟骨再生医療市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 軟骨再生医療セグメント、タイプ別
2.2.1 セルベース
2.2.2 非セルベース
2.3 軟骨再生医療市場規模：タイプ別
2.3.1 軟骨再生医療市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの軟骨再生医療市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 軟骨再生医療セグメント、用途別
2.4.1 ヒアリン軟骨の修復と再生
2.4.2 弾性軟骨の修復と再生
2.4.3 線維性軟骨の修復と再生
2.5 軟骨再生医療市場規模：用途別
2.5.1 軟骨再生医療市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの軟骨再生医療市場規模、市場シェア（用途別）（2018年～2023年）
3 軟骨再生医療市場規模：プレイヤー別
3.1 軟骨再生医療市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける軟骨再生医療市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける軟骨再生医療市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの軟骨再生医療市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 軟骨再生医療、地域別
4.1 軟骨再生医療市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける軟骨再生医療市場規模成長（2018年〜2023年）
4.3 APACにおける軟骨再生医療市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける軟骨再生医療市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける軟骨再生医療市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける軟骨再生医療市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける軟骨再生医療市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける軟骨再生医療市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける軟骨再生医療市場規模、地域別（2018年〜2023年）
6.2 APACにおける軟骨再生医療市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける軟骨再生医療市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの軟骨再生医療 国別（2018年～2023年）
7.2 ヨーロッパにおける軟骨再生医療市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける軟骨再生医療市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの軟骨再生医療 地域別（2018年～2023年）
8.2 中東・アフリカにおける軟骨再生医療市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける軟骨再生医療市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの軟骨再生医療市場、市場予測
10.1 グローバルの軟骨再生医療、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの軟骨再生医療、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの軟骨再生医療、市場予測
10.1.3 APACの軟骨再生医療、市場予測
10.1.4 ヨーロッパの軟骨再生医療、市場予測
10.1.5 中東・アフリカの軟骨再生医療、市場予測
10.2 アメリカズの軟骨再生医療、市場予測（国別）（2024年～2029年）
10.3 APACの軟骨再生医療、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの軟骨再生医療、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの軟骨再生医療、市場予測（地域別）（2024年～2029年）
10.6 グローバルの軟骨再生医療、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの軟骨再生医療、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 B\. Braun Melsungen AG
11.1.1 B\. Braun Melsungen AG：企業情報
11.1.2 B\. Braun Melsungen AG：軟骨再生医療分野の提供製品
11.1.3 B\. Braun Melsungen AG：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 B\. Braun Melsungen AG：主要事業概要
11.1.5 B\. Braun Melsungen AG：直近の展開
11.2 Zimmer Biomet Holdings Inc
11.3 Vericel Corporation
11.3.1 Vericel Corporation：企業情報
11.3.2 Vericel Corporation：軟骨再生医療分野の提供製品
11.3.3 Vericel Corporation：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Vericel Corporation：主要事業概要
11.3.5 Vericel Corporation：直近の展開
11.4 Stryker Corporation
11.4.1 Stryker Corporation：企業情報
11.4.2 Stryker Corporation：軟骨再生医療分野の提供製品
11.4.3 Stryker Corporation：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Stryker Corporation：主要事業概要
11.4.5 Stryker Corporation：直近の展開
11.5 Smith & Nephew plc
11.5.1 Smith & Nephew plc：企業情報
11.5.2 Smith & Nephew plc：軟骨再生医療分野の提供製品
11.5.3 Smith & Nephew plc：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.5.4 Smith & Nephew plc：主要事業概要
11.5.5 Smith & Nephew plc：直近の展開
11.6 Arthrex Inc
11.7 CONMED Corporation
11.7.1 CONMED Corporation：企業情報
11.7.2 CONMED Corporation：軟骨再生医療分野の提供製品
11.7.3 CONMED Corporation：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 CONMED Corporation：主要事業概要
11.7.5 CONMED Corporation：直近の展開
11.8 Collagen Solutions PLC
11.8.1 Collagen Solutions PLC：企業情報
11.8.2 Collagen Solutions PLC：軟骨再生医療分野の提供製品
11.8.3 Collagen Solutions PLC：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Collagen Solutions PLC：主要事業概要
11.8.5 Collagen Solutions PLC：直近の展開
11.9 BioTissue Technologies
11.9.1 BioTissue Technologies：企業情報
11.9.2 BioTissue Technologies：軟骨再生医療分野の提供製品
11.9.3 BioTissue Technologies：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 BioTissue Technologies：主要事業概要
11.9.5 BioTissue Technologies：直近の展開
11.10 CellGenix
11.10.1 CellGenix：企業情報
11.10.2 CellGenix：軟骨再生医療分野の提供製品
11.10.3 CellGenix：軟骨再生医療収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 CellGenix：主要事業概要
11.10.5 CellGenix：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Regenerative Medicine for Cartilage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Regenerative Medicine for Cartilage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Regenerative Medicine for Cartilage market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Regenerative Medicine for Cartilage and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Regenerative Medicine for Cartilage.
The global Regenerative Medicine for Cartilage market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Regenerative Medicine for Cartilage is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Regenerative Medicine for Cartilage players cover B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC and BioTissue Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Regenerative Medicine for Cartilage market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Cell-based
Non-cell-based
Segmentation by application
Hyaline Cartilage Repair and Regeneration
Elastic Cartilage Repair and Regeneration
Ribrous Cartilage Repair and Regeneration.
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
B. Braun Melsungen AG
Zimmer Biomet Holdings Inc.
Vericel Corporation
Stryker Corporation
Smith & Nephew plc
Arthrex Inc.
CONMED Corporation
Collagen Solutions PLC
BioTissue Technologies
CellGenix
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Regenerative Medicine for Cartilage Market Size 2018-2029
2.1.2 Regenerative Medicine for Cartilage Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Regenerative Medicine for Cartilage Segment by Type
2.2.1 Cell-based
2.2.2 Non-cell-based
2.3 Regenerative Medicine for Cartilage Market Size by Type
2.3.1 Regenerative Medicine for Cartilage Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023)
2.4 Regenerative Medicine for Cartilage Segment by Application
2.4.1 Hyaline Cartilage Repair and Regeneration
2.4.2 Elastic Cartilage Repair and Regeneration
2.4.3 Ribrous Cartilage Repair and Regeneration.
2.5 Regenerative Medicine for Cartilage Market Size by Application
2.5.1 Regenerative Medicine for Cartilage Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023)
3 Regenerative Medicine for Cartilage Market Size by Player
3.1 Regenerative Medicine for Cartilage Market Size Market Share by Players
3.1.1 Global Regenerative Medicine for Cartilage Revenue by Players (2018-2023)
3.1.2 Global Regenerative Medicine for Cartilage Revenue Market Share by Players (2018-2023)
3.2 Global Regenerative Medicine for Cartilage Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Regenerative Medicine for Cartilage by Regions
4.1 Regenerative Medicine for Cartilage Market Size by Regions (2018-2023)
4.2 Americas Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
4.3 APAC Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
4.4 Europe Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
4.5 Middle East & Africa Regenerative Medicine for Cartilage Market Size Growth (2018-2023)
5 Americas
5.1 Americas Regenerative Medicine for Cartilage Market Size by Country (2018-2023)
5.2 Americas Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
5.3 Americas Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Regenerative Medicine for Cartilage Market Size by Region (2018-2023)
6.2 APAC Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
6.3 APAC Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Regenerative Medicine for Cartilage by Country (2018-2023)
7.2 Europe Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
7.3 Europe Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Regenerative Medicine for Cartilage by Region (2018-2023)
8.2 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2018-2023)
8.3 Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Regenerative Medicine for Cartilage Market Forecast
10.1 Global Regenerative Medicine for Cartilage Forecast by Regions (2024-2029)
10.1.1 Global Regenerative Medicine for Cartilage Forecast by Regions (2024-2029)
10.1.2 Americas Regenerative Medicine for Cartilage Forecast
10.1.3 APAC Regenerative Medicine for Cartilage Forecast
10.1.4 Europe Regenerative Medicine for Cartilage Forecast
10.1.5 Middle East & Africa Regenerative Medicine for Cartilage Forecast
10.2 Americas Regenerative Medicine for Cartilage Forecast by Country (2024-2029)
10.2.1 United States Regenerative Medicine for Cartilage Market Forecast
10.2.2 Canada Regenerative Medicine for Cartilage Market Forecast
10.2.3 Mexico Regenerative Medicine for Cartilage Market Forecast
10.2.4 Brazil Regenerative Medicine for Cartilage Market Forecast
10.3 APAC Regenerative Medicine for Cartilage Forecast by Region (2024-2029)
10.3.1 China Regenerative Medicine for Cartilage Market Forecast
10.3.2 Japan Regenerative Medicine for Cartilage Market Forecast
10.3.3 Korea Regenerative Medicine for Cartilage Market Forecast
10.3.4 Southeast Asia Regenerative Medicine for Cartilage Market Forecast
10.3.5 India Regenerative Medicine for Cartilage Market Forecast
10.3.6 Australia Regenerative Medicine for Cartilage Market Forecast
10.4 Europe Regenerative Medicine for Cartilage Forecast by Country (2024-2029)
10.4.1 Germany Regenerative Medicine for Cartilage Market Forecast
10.4.2 France Regenerative Medicine for Cartilage Market Forecast
10.4.3 UK Regenerative Medicine for Cartilage Market Forecast
10.4.4 Italy Regenerative Medicine for Cartilage Market Forecast
10.4.5 Russia Regenerative Medicine for Cartilage Market Forecast
10.5 Middle East & Africa Regenerative Medicine for Cartilage Forecast by Region (2024-2029)
10.5.1 Egypt Regenerative Medicine for Cartilage Market Forecast
10.5.2 South Africa Regenerative Medicine for Cartilage Market Forecast
10.5.3 Israel Regenerative Medicine for Cartilage Market Forecast
10.5.4 Turkey Regenerative Medicine for Cartilage Market Forecast
10.5.5 GCC Countries Regenerative Medicine for Cartilage Market Forecast
10.6 Global Regenerative Medicine for Cartilage Forecast by Type (2024-2029)
10.7 Global Regenerative Medicine for Cartilage Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 B. Braun Melsungen AG
11.1.1 B. Braun Melsungen AG Company Information
11.1.2 B. Braun Melsungen AG Regenerative Medicine for Cartilage Product Offered
11.1.3 B. Braun Melsungen AG Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 B. Braun Melsungen AG Main Business Overview
11.1.5 B. Braun Melsungen AG Latest Developments
11.2 Zimmer Biomet Holdings Inc.
11.2.1 Zimmer Biomet Holdings Inc. Company Information
11.2.2 Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Product Offered
11.2.3 Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Zimmer Biomet Holdings Inc. Main Business Overview
11.2.5 Zimmer Biomet Holdings Inc. Latest Developments
11.3 Vericel Corporation
11.3.1 Vericel Corporation Company Information
11.3.2 Vericel Corporation Regenerative Medicine for Cartilage Product Offered
11.3.3 Vericel Corporation Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Vericel Corporation Main Business Overview
11.3.5 Vericel Corporation Latest Developments
11.4 Stryker Corporation
11.4.1 Stryker Corporation Company Information
11.4.2 Stryker Corporation Regenerative Medicine for Cartilage Product Offered
11.4.3 Stryker Corporation Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Stryker Corporation Main Business Overview
11.4.5 Stryker Corporation Latest Developments
11.5 Smith & Nephew plc
11.5.1 Smith & Nephew plc Company Information
11.5.2 Smith & Nephew plc Regenerative Medicine for Cartilage Product Offered
11.5.3 Smith & Nephew plc Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Smith & Nephew plc Main Business Overview
11.5.5 Smith & Nephew plc Latest Developments
11.6 Arthrex Inc.
11.6.1 Arthrex Inc. Company Information
11.6.2 Arthrex Inc. Regenerative Medicine for Cartilage Product Offered
11.6.3 Arthrex Inc. Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Arthrex Inc. Main Business Overview
11.6.5 Arthrex Inc. Latest Developments
11.7 CONMED Corporation
11.7.1 CONMED Corporation Company Information
11.7.2 CONMED Corporation Regenerative Medicine for Cartilage Product Offered
11.7.3 CONMED Corporation Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CONMED Corporation Main Business Overview
11.7.5 CONMED Corporation Latest Developments
11.8 Collagen Solutions PLC
11.8.1 Collagen Solutions PLC Company Information
11.8.2 Collagen Solutions PLC Regenerative Medicine for Cartilage Product Offered
11.8.3 Collagen Solutions PLC Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Collagen Solutions PLC Main Business Overview
11.8.5 Collagen Solutions PLC Latest Developments
11.9 BioTissue Technologies
11.9.1 BioTissue Technologies Company Information
11.9.2 BioTissue Technologies Regenerative Medicine for Cartilage Product Offered
11.9.3 BioTissue Technologies Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 BioTissue Technologies Main Business Overview
11.9.5 BioTissue Technologies Latest Developments
11.10 CellGenix
11.10.1 CellGenix Company Information
11.10.2 CellGenix Regenerative Medicine for Cartilage Product Offered
11.10.3 CellGenix Regenerative Medicine for Cartilage Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 CellGenix Main Business Overview
11.10.5 CellGenix Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Regenerative Medicine for Cartilage Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Cell-based Table 3. Major Players of Non-cell-based Table 4. Regenerative Medicine for Cartilage Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Regenerative Medicine for Cartilage Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Table 7. Regenerative Medicine for Cartilage Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Regenerative Medicine for Cartilage Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Table 10. Global Regenerative Medicine for Cartilage Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Regenerative Medicine for Cartilage Revenue Market Share by Player (2018-2023) Table 12. Regenerative Medicine for Cartilage Key Players Head office and Products Offered Table 13. Regenerative Medicine for Cartilage Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Regenerative Medicine for Cartilage Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Regenerative Medicine for Cartilage Market Size Market Share by Regions (2018-2023) Table 18. Global Regenerative Medicine for Cartilage Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Regenerative Medicine for Cartilage Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Regenerative Medicine for Cartilage Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Regenerative Medicine for Cartilage Market Size Market Share by Country (2018-2023) Table 22. Americas Regenerative Medicine for Cartilage Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Table 24. Americas Regenerative Medicine for Cartilage Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Table 26. APAC Regenerative Medicine for Cartilage Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Regenerative Medicine for Cartilage Market Size Market Share by Region (2018-2023) Table 28. APAC Regenerative Medicine for Cartilage Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Table 30. APAC Regenerative Medicine for Cartilage Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Table 32. Europe Regenerative Medicine for Cartilage Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Regenerative Medicine for Cartilage Market Size Market Share by Country (2018-2023) Table 34. Europe Regenerative Medicine for Cartilage Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Table 36. Europe Regenerative Medicine for Cartilage Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Regenerative Medicine for Cartilage Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Regenerative Medicine for Cartilage Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Regenerative Medicine for Cartilage Table 45. Key Market Challenges & Risks of Regenerative Medicine for Cartilage Table 46. Key Industry Trends of Regenerative Medicine for Cartilage Table 47. Global Regenerative Medicine for Cartilage Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Regenerative Medicine for Cartilage Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Regenerative Medicine for Cartilage Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Regenerative Medicine for Cartilage Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. B. Braun Melsungen AG Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 52. B. Braun Melsungen AG Regenerative Medicine for Cartilage Product Offered Table 53. B. Braun Melsungen AG Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. B. Braun Melsungen AG Main Business Table 55. B. Braun Melsungen AG Latest Developments Table 56. Zimmer Biomet Holdings Inc. Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 57. Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Product Offered Table 58. Zimmer Biomet Holdings Inc. Main Business Table 59. Zimmer Biomet Holdings Inc. Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Zimmer Biomet Holdings Inc. Latest Developments Table 61. Vericel Corporation Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 62. Vericel Corporation Regenerative Medicine for Cartilage Product Offered Table 63. Vericel Corporation Main Business Table 64. Vericel Corporation Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. Vericel Corporation Latest Developments Table 66. Stryker Corporation Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 67. Stryker Corporation Regenerative Medicine for Cartilage Product Offered Table 68. Stryker Corporation Main Business Table 69. Stryker Corporation Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. Stryker Corporation Latest Developments Table 71. Smith & Nephew plc Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 72. Smith & Nephew plc Regenerative Medicine for Cartilage Product Offered Table 73. Smith & Nephew plc Main Business Table 74. Smith & Nephew plc Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. Smith & Nephew plc Latest Developments Table 76. Arthrex Inc. Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 77. Arthrex Inc. Regenerative Medicine for Cartilage Product Offered Table 78. Arthrex Inc. Main Business Table 79. Arthrex Inc. Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 80. Arthrex Inc. Latest Developments Table 81. CONMED Corporation Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 82. CONMED Corporation Regenerative Medicine for Cartilage Product Offered Table 83. CONMED Corporation Main Business Table 84. CONMED Corporation Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 85. CONMED Corporation Latest Developments Table 86. Collagen Solutions PLC Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 87. Collagen Solutions PLC Regenerative Medicine for Cartilage Product Offered Table 88. Collagen Solutions PLC Main Business Table 89. Collagen Solutions PLC Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 90. Collagen Solutions PLC Latest Developments Table 91. BioTissue Technologies Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 92. BioTissue Technologies Regenerative Medicine for Cartilage Product Offered Table 93. BioTissue Technologies Main Business Table 94. BioTissue Technologies Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 95. BioTissue Technologies Latest Developments Table 96. CellGenix Details, Company Type, Regenerative Medicine for Cartilage Area Served and Its Competitors Table 97. CellGenix Regenerative Medicine for Cartilage Product Offered Table 98. CellGenix Main Business Table 99. CellGenix Regenerative Medicine for Cartilage Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 100. CellGenix Latest Developments List of Figures Figure 1. Regenerative Medicine for Cartilage Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Regenerative Medicine for Cartilage Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Regenerative Medicine for Cartilage Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Regenerative Medicine for Cartilage Sales Market Share by Country/Region (2022) Figure 8. Regenerative Medicine for Cartilage Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Regenerative Medicine for Cartilage Market Size Market Share by Type in 2022 Figure 10. Regenerative Medicine for Cartilage in Hyaline Cartilage Repair and Regeneration Figure 11. Global Regenerative Medicine for Cartilage Market: Hyaline Cartilage Repair and Regeneration (2018-2023) & ($ Millions) Figure 12. Regenerative Medicine for Cartilage in Elastic Cartilage Repair and Regeneration Figure 13. Global Regenerative Medicine for Cartilage Market: Elastic Cartilage Repair and Regeneration (2018-2023) & ($ Millions) Figure 14. Regenerative Medicine for Cartilage in Ribrous Cartilage Repair and Regeneration. Figure 15. Global Regenerative Medicine for Cartilage Market: Ribrous Cartilage Repair and Regeneration. (2018-2023) & ($ Millions) Figure 16. Global Regenerative Medicine for Cartilage Market Size Market Share by Application in 2022 Figure 17. Global Regenerative Medicine for Cartilage Revenue Market Share by Player in 2022 Figure 18. Global Regenerative Medicine for Cartilage Market Size Market Share by Regions (2018-2023) Figure 19. Americas Regenerative Medicine for Cartilage Market Size 2018-2023 ($ Millions) Figure 20. APAC Regenerative Medicine for Cartilage Market Size 2018-2023 ($ Millions) Figure 21. Europe Regenerative Medicine for Cartilage Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Regenerative Medicine for Cartilage Market Size 2018-2023 ($ Millions) Figure 23. Americas Regenerative Medicine for Cartilage Value Market Share by Country in 2022 Figure 24. United States Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Regenerative Medicine for Cartilage Market Size Market Share by Region in 2022 Figure 29. APAC Regenerative Medicine for Cartilage Market Size Market Share by Type in 2022 Figure 30. APAC Regenerative Medicine for Cartilage Market Size Market Share by Application in 2022 Figure 31. China Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 35. India Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Regenerative Medicine for Cartilage Market Size Market Share by Country in 2022 Figure 38. Europe Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Figure 39. Europe Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Figure 40. Germany Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 41. France Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Regenerative Medicine for Cartilage Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Regenerative Medicine for Cartilage Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Regenerative Medicine for Cartilage Market Size Market Share by Application (2018-2023) Figure 48. Egypt Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Regenerative Medicine for Cartilage Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 54. APAC Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 55. Europe Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 57. United States Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 58. Canada Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 59. Mexico Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 60. Brazil Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 61. China Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 62. Japan Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 63. Korea Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 65. India Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 66. Australia Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 67. Germany Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 68. France Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 69. UK Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 70. Italy Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 71. Russia Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 72. Spain Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 73. Egypt Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 74. South Africa Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 75. Israel Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 76. Turkey Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Regenerative Medicine for Cartilage Market Size 2024-2029 ($ Millions) Figure 78. Global Regenerative Medicine for Cartilage Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Regenerative Medicine for Cartilage Market Size Market Share Forecast by Application (2024-2029)
